Jonathan E. Lim - 27 Mar 2024 Form 3 Insider Report for Boundless Bio, Inc. (BOLD)

Role
Director
Signature
/s/ Jessica Oien, Attorney-in-Fact for Jonathan Lim
Issuer symbol
BOLD
Transactions as of
27 Mar 2024
Net transactions value
$0
Form type
3
Filing time
27 Mar 2024, 20:00:22 UTC
Previous filing
07 Feb 2024
Next filing
04 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BOLD Common Stock 102,564 27 Mar 2024 Direct
holding BOLD Common Stock 25,641 27 Mar 2024 By City Hill, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BOLD Series A Convertible Preferred Stock 27 Mar 2024 Common Stock 512,820 By City Hill, LLC F1, F2
holding BOLD Series B Convertible Preferred Stock 27 Mar 2024 Common Stock 5,128 By City Hill, LLC F1, F2
holding BOLD Series C Convertible Preferred Stock 27 Mar 2024 Common Stock 7,326 By City Hill, LLC F1, F2
holding BOLD Stock Option 27 Mar 2024 Common Stock 10,256 $4.10 Direct F3
holding BOLD Stock Option 27 Mar 2024 Common Stock 17,435 $4.10 Direct F4
holding BOLD Stock Option 27 Mar 2024 Common Stock 13,846 $8.19 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.
F2 Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
F3 The stock option vests in 36 substantially equal monthly installments beginning on July 7, 2021.
F4 The stock option vests in 36 substantially equal monthly installments beginning on July 13, 2023.
F5 The stock option vests in 36 substantially equal monthly installments beginning on March 15, 2024.

Remarks:

Exhibit 24 - Power of Attorney.